课题基金 / 基金详情

TOPIC 403: DEVELOPMENT OF SPATIAL MICROPURIFICATION TECHNOLOGY

TOPIC 403: DEVELOPMENT OF SPATIAL MICROPURIFICATION TECHNOLOGY
主题 403:空间微净化技术的发展
批准号:
10724142
负责人:
MICHAEL EMMERT-BUCK
金额:
$199.94万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-19 至 2024-09-18

项目摘要

项目成果

MICHAEL EMMERT-BUCK的其他基金

相似基金

相关文献

中文摘要
翻译
肿瘤微环境(TME)由多种细胞类型组成,包括肿瘤细胞、肿瘤亚克隆、化生、不典型增生、结缔组织增生、反应性成纤维细胞和复杂的免疫反应。测量TME中每个细胞成分的分子状态对于了解肿瘤的发生和发展以及确定癌症与正常宿主细胞之间的相互作用非常重要。
英文摘要
The tumor microenvironment (TME) comprises a mixture of cell types, including tumor cells, cancer sub-clones, metaplasia, dysplasia, desmoplasia, reactive fibroblasts, and a complex immune response. Measuring the molecular status of each cellular component within the TME is important to understanding tumor initiation and progression as well as in determining the interplay between cancer and normal host cells. The proposal describes a new DNA sequencing and genomic analysis technology for histological slides called spatial micropurification, which can be developed into a commercial device that permits localized, cell-specific interrogation of the TME. SMP devices can analyze individual target cells, called single cell spatial micropurification (Single-Cell SMP), or can procure groups of target cells of the same lineage, such as tumor cells or lymphocytes, called multiple cell spatial micropurification (Multi-Cell SMP). Together, the two versions of SMP provide a flexible platform for genomic analyses of the cancer tumor microenvironment (TME) that investigators can employ to meet their research and clinical needs. Development and deployment of this novel technology for spatial molecular profiling of tumors will provide a deeper understanding of the relationship between cell genotype and morphology, providing valuable information toward development of new diagnostic, prognostic, or therapeutic interventions in patients with cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SBIR TOPIC 403 PHASE I: DEVELOPMENT OF SPATIAL MICRO-PURIFICATION TECHNOLOGY
  • 批准号:
    10280937
  • 项目类别:
  • 资助金额:
    $39.91万
  • 财政年份:
    2020
  • 负责人:
    MICHAEL EMMERT-BUCK
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
库否细胞(Kupffer cells)受体PirB/LILRB2在非酒精性脂肪性肝炎中的作用及机制研究
  • 批准号:
    82470907
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2024
  • 负责人:
    余学锋
  • 依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位: